Jinglei Miao

916 citations
21 papers · 664 indexed · h-index 13
Topics
Circular RNAs in diseases (6 papers)Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (5 papers)

In The Last Decade

Jinglei Miao

20 papers receiving 656 citations

Peers

Jinglei Miao
Comparison fields: 5 of 95
  • Molecular Biology 387
  • Cancer Research 259
  • Oncology 85
  • Biomedical Engineering 85
  • Pulmonary and Respiratory Medicine 59
Replace Qiang Xia with:
Qiang Xia China
Shi‐xin Du China
Yitao Ding China
Laijun Song China
Deming Xiao China
Xiaochen Liu China
Jinglin Wang China
Dongjun Lin China
Qifei Wu China
Yingying Tan China
Jinglei Miao relative to Qiang Xia China Qiang Xia's profile →
Citations per field
00.5×1.5×2.4×
Qiang Xia · 1×
Citations per year

Countries citing papers authored by Jinglei Miao

Since Specialization
Citations

This map shows the geographic impact of Jinglei Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglei Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglei Miao more than expected).

Fields of papers citing papers by Jinglei Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinglei Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglei Miao. The network helps show where Jinglei Miao may publish in the future.

Co-authorship network of co-authors of Jinglei Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinglei Miao. A scholar is included among the top collaborators of Jinglei Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinglei Miao. Jinglei Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 3
4 2
5 21
6 26
7 0
8 67
9 110
10 16
11 62
12 40
13 34
14 21
15 75
16 108
17 20
18
[Characteristics and treatment of traumatic cervical disc herniation].
1
19 51
20
Feasibility of endoscopic transoral-transpharyngeal approach to atlantoaxis
2

About Jinglei Miao

Jinglei Miao is a scholar working on Cancer Research, Pharmacology and Molecular Biology, having authored 21 papers that have together received 664 indexed citations. Recurring topics across this work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (259 citations), Pharmacology (51 citations) and Molecular Biology (387 citations). Jinglei Miao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weiguo Wang, Shijie Chen, Yuezhan Li, Zhiyu Ding, Mousumi Tania, Chaoyue Zhang, Song Wu, Minghua Hu, Jianlong Wang and Shuang Zhi. Their work appears in journals such as Small, Journal of Cellular Biochemistry and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026